Viewing nowNeurobalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
White Life Science Co., Ltd.

MFDS item code 201901934 · Approved 2019.03.29 · Insurance code 625201860
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It also helps in the adjunctive management of partial seizures in patients with epilepsy. Additionally, it is effective in alleviating symptoms of fibromyalgia. It contributes to improving the quality of life of patients suffering from various neurological disorders.
This medication is administered orally, with or without food, as pregabalin in the total daily dose divided into 2 doses. Since this medication is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See “5. Patients with Renal Impairment”) 1. Neuropathic Pain 1) Peripheral Neuropathic Pain Adults: This medication may be administered at an initial dose of 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central Neuropathic Pain Adults: This medication may be administered at an initial dose of 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See “4. Discontinuation of Treatment”) 2. Epilepsy Adults: This medication may be administered at an initial dose of 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medication for fibromyalgia is 300 mg to 450 mg/day. The initial dose is 75 mg twice daily (150 mg/day), and may be increased to 150 mg twice daily (300 mg/day) within 1 week based on efficacy and tolerability. For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased to 225 mg twice daily (450 mg/day) within 1 week. Clinical studies have also been conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of Treatment Based on current clinical experience, if treatment with this medication is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with Renal Impairment After entering the systemic circulation, this medication is primarily excreted by the kidneys as unchanged drug. Since the clearance of this medication is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. *: For women, multiply the result obtained from the above calculation by 0.85. This medication is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin Dosage Based on Renal Function Creatinine clearance (CLcr), (mL/min) ≥60: Total daily dose of pregabalin: initial dose 150 (mg/day), maximum dose 600 (mg/day), administration BID or TID ≥30 -<60: initial dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID ≥15 -<30: initial dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID <15: initial dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: 25, 100, single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = administered once daily a: The total daily dose (mg/day) should be divided as specified under administration. b: The supplemental dose refers to a dose administered once in addition. 6. Patients with Hepatic Impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older Adults (65 years of age or older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Use is not recommended. Adolescent patients 12 ~17 years of age: Use is not recommended.
This medication may increase the risk of suicidal thoughts or behavior, so if there are any changes in mood or behavior during treatment, consult a doctor immediately. Do not take this medication if you have an allergy to any of its components or specific genetic lactose intolerance. Diabetes patients should be cautious as they may gain weight after taking this medication, which might require adjustments to their blood sugar control medications. This medication can cause serious allergic reactions such as angioedema; if you experience facial or neck swelling or difficulty breathing, stop taking the medication immediately and seek medical attention. Elderly patients are at higher risk of falling or injury due to dizziness or drowsiness when taking this medication, so caution is advised. While taking this medication, blurred vision or changes in vision may occur, and these symptoms may improve upon discontinuation of the medication. Abrupt discontinuation of this medication may cause withdrawal symptoms such as insomnia, headache, and anxiety, so the dosage should be gradually reduced according to a doctor's instructions. There is a risk of drug abuse, so patients with a history of drug abuse or mental health issues should use this medication with caution. Patients with decreased kidney function may need to adjust the dosage of this medication. Patients with severe heart disease should be cautious while taking this medication. Taking this medication with opioid analgesics may significantly enhance central nervous system depression, so consult healthcare professionals. In those with respiratory or neurological diseases, or in the elderly, there is an increased risk of severe respiratory depression, so caution is advised. Women of childbearing potential should use effective contraception when taking this medication in early pregnancy as it may be harmful to the fetus, and it is generally recommended not to take this medication during pregnancy. Caution is advised when driving or operating machinery due to the risk of accidents from dizziness and drowsiness. This medication can cause serious skin reactions, so if a rash or red spots appear, stop taking it and inform a doctor immediately. In the case of overdose, symptoms such as confusion, drowsiness, depression, and seizures may occur, so the prescribed dosage should be strictly adhered to, and treatment such as hemodialysis may be necessary if required. Keep this medication out of reach of children and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air or moisture. It is also recommended to store it at room temperature between 15 to 30 degrees Celsius, away from extreme heat or cold.
A hard capsule with a white or light yellow powder inside, with a white upper and lower part.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
White Life Science Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.